Delphine Demede
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Delphine Demede has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Valeska Bidault-Jourdainne
Service de Chirurgie Uro-Viscérale et Thoracique Pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Centre de référence MARVU, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; INSERM U1208 Stem Cell and Brain Research Institute (SBRI), Université Claude Bernard Lyon 1, Bron, France
3 shared publications - Berenice Tulelli
Service de Chirurgie Uro-Viscérale et Thoracique Pédiatrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Centre de référence MARVU, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France; Université Claude Bernard Lyon 1, Lyon, France
2 shared publications A. Fichez
Service de Gynécologie-Obstétrique, Service de Diagnostic Anténatal, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
1 shared publication- Aurore Bouty
The Royal Children’s Hospital
1 shared publication - Aurélien Scalabre
Pediatric Surgery Unit, CHU de Saint Etienne, Saint. Etienne, France
1 shared publication Axel Fichez
Multidisciplinary Center for Prenatal Diagnosis (CPDPN), Hôpital de la Croix-Rousse , 69000 Lyon
1 shared publication
Latest Publications
- Open Access
- 24 July 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
Prenatal care for disorders/differences of sex development: 10 years look back in an expert center
Context: Phenotypic presentations and etiologies of disorders/differences of sex development (DSD) are variable. While postnatal management is well described, no consensus exists regarding prenatal care, despite increasingly frequent detection. Objective: To describe prenatal management practices of isolated ultrasound suspicion of DSD referred to the Multidisciplinary Center for Prenatal Diagnosis (MCPD) of Lyon over a 10-year period. Methods: Retrospective study of pregnancies referred to MCPD between January 2013 and December 2022 for isolated ultrasound suspicion of DSD. Fetuses referred for family history risk were not included. DSD were considered isolated when no additional malformation was suspected at referral, except minor cardiac anomalies, renal pelvis or ureteral dilation, and intrauterine growth restriction (IUGR). Results: Of 71 patients referred for suspected isolated DSD, 57 were confirmed by experts. At birth, 52.3% newborn were preterm and 52.3% had IUGR. Among the 57 prenatally suspicion, 41 children presented a DSD phenotype. SRY testing on maternal blood was performed in 17.5% of cases and invasive examination was performed in 59.6% of cases. Amniotic fluid analyses included steroid profile (76.5%), biochemical analyses for Smith-Lemli-Opitz (SLO) syndrome (64.7%), and genetic analyses (100%). Genetic analyses comprised karyotype (100%), comparative genomic hybridization array (67.6%), DSD panel (14.7%), targeted gene analysis (35.3%). A molecular diagnosis was obtained in 13 cases, including 5 prenatally. Three fetuses were ultimately diagnosed with severe neurological conditions. Conclusion: Prenatal assessment may support counseling and care planning for families expecting a child with DSD. Further prospective studies are necessary to confirm these findings and formulate recommendations for prenatal management of DSD.
- 24 July 2026
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
Open AccessPrenatal care for disorders/differences of sex development: 10 years look back in an expert center
Context: Phenotypic presentations and etiologies of disorders/differences of sex development (DSD) are variable. While postnatal management is well described, no consensus exists regarding prenatal care, despite increasingly frequent detection. Objective: To describe prenatal management practices of isolated ultrasound suspicion of DSD referred to the Multidisciplinary Center for Prenatal Diagnosis (MCPD) of Lyon over a 10-year period. Methods: Retrospective study of pregnancies referred to MCPD between January 2013 and December 2022 for isolated ultrasound suspicion of DSD. Fetuses referred for family history risk were not included. DSD were considered isolated when no additional malformation was suspected at referral, except minor cardiac anomalies, renal pelvis or ureteral dilation, and intrauterine growth restriction (IUGR). Results: Of 71 patients referred for suspected isolated DSD, 57 were confirmed by experts. At birth, 52.3% newborn were preterm and 52.3% had IUGR. Among the 57 prenatally suspicion, 41 children presented a DSD phenotype. SRY testing on maternal blood was performed in 17.5% of cases and invasive examination was performed in 59.6% of cases. Amniotic fluid analyses included steroid profile (76.5%), biochemical analyses for Smith-Lemli-Opitz (SLO) syndrome (64.7%), and genetic analyses (100%). Genetic analyses comprised karyotype (100%), comparative genomic hybridization array (67.6%), DSD panel (14.7%), targeted gene analysis (35.3%). A molecular diagnosis was obtained in 13 cases, including 5 prenatally. Three fetuses were ultimately diagnosed with severe neurological conditions. Conclusion: Prenatal assessment may support counseling and care planning for families expecting a child with DSD. Further prospective studies are necessary to confirm these findings and formulate recommendations for prenatal management of DSD.
- Open Access
- 12 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106005
Prenatal and postnatal outcomes of foetal megacystis: What to expect when posterior urethral valves are excluded? A retrospective multicentre study
- 12 May 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106005
Open AccessPrenatal and postnatal outcomes of foetal megacystis: What to expect when posterior urethral valves are excluded? A retrospective multicentre study
- Open Access
- 3 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (6) , 163048
Paediatric robotic surgery simulation: Results of a national survey and scoping review
- 3 March 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (6) , 163048
Open AccessPaediatric robotic surgery simulation: Results of a national survey and scoping review
- Open Access
- 4 August 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Early detection of ureteropelvic junction obstruction in neonates with prenatal diagnosis of renal pelvis dilatation using 1H NMR urinary metabolomics
Renal pelvis dilatation (RPD) is diagnosed in utero on prenatal ultrasonography (US) and can resolve spontaneously. However, isolated RPD can also reflect ureteropelvic junction obstruction (UPJO), which requires surgical treatment to prevent progressive renal deterioration. The diagnosis of UPJO can only be confirmed after birth with repeat US and renal isotope studies. 1H Nuclear Magnetic Resonance spectroscopy (NMR) was performed on urine of newborns with prenatally diagnosed unilateral RPD and healthy controls to identify specific urinary biomarkers for UPJO. The original combination of EigenMS normalization and sparse partial-least-squares discriminant analysis improved selectivity and sensitivity. In total, 140 urine samples from newborns were processed and 100 metabolites were identified. Correlation network identified discriminant metabolites in lower concentrations in UPJO patients. Two main metabolic pathways appeared to be impaired in patients with UPJO i.e. amino acid and betaine metabolism. In this prospective study, metabolic profiling of urine samples by NMR clearly distinguishes patients who required surgery for UPJO from patients with transient dilatations and controls. This study will pave the way for the use of metabolomics for the diagnosis of prenatal hydronephrosis in clinical routine.
- 4 August 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Open AccessEarly detection of ureteropelvic junction obstruction in neonates with prenatal diagnosis of renal pelvis dilatation using 1H NMR urinary metabolomics
Renal pelvis dilatation (RPD) is diagnosed in utero on prenatal ultrasonography (US) and can resolve spontaneously. However, isolated RPD can also reflect ureteropelvic junction obstruction (UPJO), which requires surgical treatment to prevent progressive renal deterioration. The diagnosis of UPJO can only be confirmed after birth with repeat US and renal isotope studies. 1H Nuclear Magnetic Resonance spectroscopy (NMR) was performed on urine of newborns with prenatally diagnosed unilateral RPD and healthy controls to identify specific urinary biomarkers for UPJO. The original combination of EigenMS normalization and sparse partial-least-squares discriminant analysis improved selectivity and sensitivity. In total, 140 urine samples from newborns were processed and 100 metabolites were identified. Correlation network identified discriminant metabolites in lower concentrations in UPJO patients. Two main metabolic pathways appeared to be impaired in patients with UPJO i.e. amino acid and betaine metabolism. In this prospective study, metabolic profiling of urine samples by NMR clearly distinguishes patients who required surgery for UPJO from patients with transient dilatations and controls. This study will pave the way for the use of metabolomics for the diagnosis of prenatal hydronephrosis in clinical routine.